18.09.2015 13:16:05
|
Cempra's Taksta Gets Qualified Infectious Disease Product Designation From FDA
(RTTNews) - Clinical-stage pharmaceutical company Cempra, Inc. (CEMP) Friday said it's investigational antibiotic product candidate Taksta received qualified infectious disease product designation from FDA. The compound is intended to treat acute bacterial skin and skin structure infections.
The approval is for the Oral tablets. Cempra is exploring the use of the compound for long term treatment for refractory bone and joint infections.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cempra Holdings LLCmehr Nachrichten
Keine Nachrichten verfügbar. |